Tech Company Financing Transactions
Remedy Pharmaceuticals Funding Round
Private investors invested in a $292.5 thousand funding round for Remedy Pharmaceuticals. The financing round was announced on 3/6/2012.
Transaction Overview
Company Name
Announced On
3/6/2012
Transaction Type
Venture Equity
Amount
$292,506
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing amended.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
233 Bdwy. 1750
New York, NY 10279
USA
New York, NY 10279
USA
Phone
Email Address
Overview
Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
David Geliebter
Chief Executive Officer
Sven Jacobson
VP - R & D
Thomas MacAllister
VP - Regulatory Affairs
Ann Tunstall
Browse more venture capital transactions:
Prev: 3/6/2012: Verdant Power venture capital transaction
Next: 3/6/2012: Nasty Gal venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs